ArticleBlood advances2023

Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma.

Tycel J Phillips et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.